相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterizing the willingness to undergo treatment in patients with alopecia areata
Lauren F. O'Connor et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2022)
Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
Hassiel Aurelio Ramirez-Marin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2022)
Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
Kathleen W. Wyrwich et al.
DERMATOLOGY AND THERAPY (2022)
Alopecia areata: baricitinib lets the hair back to grow
Susanne Krome
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2022)
Two Phase 3 Trials of Baricitinib for Alopecia Areata
Brett King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
Kerry-Ann L. Dillon
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2021)
Application of Discrete Choice Experiment in Health Care: A Bibliometric Analysis
Yue Wang et al.
FRONTIERS IN PUBLIC HEALTH (2021)
Benefit-Risk or Risk-Benefit Trade-Offs? Another Look at Attribute Ordering Effects in a Pilot Choice Experiment
Sebastian Heidenreich et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2021)
Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis
Masayoshi Harigai
RHEUMATOLOGY (2019)
The Internal Validity of Discrete Choice Experiment Data: A Testing Tool for Quantitative Assessments
F. Reed Johnson et al.
VALUE IN HEALTH (2019)
Including Opt-Out Options in Discrete Choice Experiments: Issues to Consider
Danny Campbell et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2019)
Assessing Rationality in Discrete Choice Experiments in Health: An Investigation into the Use of Dominance Tests
Tommi Tervonen et al.
VALUE IN HEALTH (2018)
The Benefits and Challenges of Using Patient Decision Aids to Support Shared Decision Making in Health Care
Anshu Ankolekar et al.
JCO CLINICAL CANCER INFORMATICS (2018)
Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability?
Ellen M. Janssen et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2017)
Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective
Axel C. Muehlbacher et al.
VALUE IN HEALTH (2016)
Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force
A. Brett Hauber et al.
VALUE IN HEALTH (2016)
Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective
F. Reed Johnson et al.
VALUE IN HEALTH (2016)
Overview of Alopecia Areata
Maria K. Hordinsky
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2013)
Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
F. Reed Johnson et al.
VALUE IN HEALTH (2013)
Discrete choice experiments in health economics: a review of the literature
Esther W. de Bekker-Grob et al.
HEALTH ECONOMICS (2012)
Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2
David C. Hoaglin et al.
VALUE IN HEALTH (2011)
Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
Jeroen P. Jansen et al.
VALUE IN HEALTH (2011)
Applicability of Internationally Available Health Literacy Measures in the Netherlands
M. P. Fransen et al.
JOURNAL OF HEALTH COMMUNICATION (2011)
Conducting discrete choice experiments to inform Healthcare decision making
Emily Lancsar et al.
PHARMACOECONOMICS (2008)
General performance on a numeracy scale among highly educated samples
IM Lipkus et al.
MEDICAL DECISION MAKING (2001)
分享论文
